<?xml version="1.0" encoding="UTF-8"?>
<p>Several other studies suggest that anti-diabetic drugs such as exenatide and metformin are neuroprotective in several models of PD and in patients [
 <xref rid="ref090" ref-type="bibr">90, 91</xref>]. Metformin and exenatide both act by lowering the levels of glucose. In addition, metformin can also directly scavenge MGO, giving rise to a non-toxic imidazolinone compound [
 <xref rid="ref092" ref-type="bibr">92</xref>].
</p>
